Summary
By Cara Baruzzi Register Business Editor
BRANFORD -- Neurogen Corp. stockholders Wednesday approved a deal in which Ligand Pharmaceuticals Inc. will acquire the local biotech firm, closing its local site.See the full content of this document
Extract
Almost Gone?
"Shareholders voted in favor of the deal and we are moving toward closing the deal as planned," s...
See the full content of this document
Sponsored links
